Protocolsβ€ΊAdvanced Longevity Stack
AdvancedLongevity16 weeks

Advanced Longevity Stack

Comprehensive multi-system rejuvenation targeting mitochondrial function, epigenetic age, telomere biology, and GH axis restoration

Patient profile: Adults 50+ with documented biological aging markers, post-menopausal women or andropausal men seeking comprehensive anti-aging intervention, or patients with premature aging phenotypes

Want a personalised protocol?

Our AI generator builds a protocol tailored to your profile and goals.

Generate protocol β†’
⚠️

This protocol is an educational example only. It does not apply to your specific health situation. Medical supervision is required. Peptide therapy is not approved by regulatory bodies for many of the described indications.

Protocol Stack

MOTS-c

Primary

Dose

5 mg

Frequency

3x/week SC

Timing

Pre-workout or morning

Duration

16 weeks

Epithalon

Primary

Dose

10 mg

Frequency

Daily SC

Timing

Evening before bed

Duration

10 days on, then repeat at week 8 (10-day course)

Thymosin Alpha-1

Supporting

Dose

1.5 mg

Frequency

2x/week SC

Timing

Morning

Duration

16 weeks

CJC-1295 (no DAC) + Ipamorelin

Supporting

Dose

100 mcg + 100 mcg

Frequency

5x/week SC

Timing

Before bed

Duration

16 weeks

Monitoring Parameters

  • βœ“Biological age test (TruAge, GrimAge, or equivalent methylation clock) β€” baseline and week 16
  • βœ“IGF-1 β€” baseline, week 8, week 16
  • βœ“Comprehensive metabolic panel β€” baseline, week 8, week 16
  • βœ“Complete blood count with differential β€” monthly
  • βœ“Telomere length (if accessible)
  • βœ“Mitochondrial function markers: CoQ10 levels, lactate/pyruvate ratio
  • βœ“DHEA-S, cortisol, testosterone/estradiol (sex-hormone panel) β€” baseline and week 16
  • βœ“VO2max or cardiorespiratory fitness test β€” baseline and week 16

Expected Outcomes

1

Weeks 1–4: Energy and sleep improvements (CJC/Ipa effect); Epithalon course 1 complete

2

Weeks 4–8: Metabolic efficiency improving (MOTS-c effect β€” AMPK activation)

3

Weeks 8–12: Epithalon course 2; IGF-1 optimization visible; immune competence improved

4

Weeks 12–16: Full stack synergy; VO2max improvement expected 8–15%

5

Post-protocol: Reassess biological age; plan maintenance based on markers

Contraindications

  • βœ—Active malignancy (absolute) β€” multiple peptides promote angiogenesis and cell proliferation
  • βœ—Uncontrolled autoimmune disease
  • βœ—Significant cardiovascular disease without cardiologist clearance
  • βœ—Recent major surgery (< 3 months)
  • βœ—Patient not willing or able to undergo comprehensive laboratory monitoring
  • βœ—Concurrent use of immunosuppressants (TA-1 may counteract)

Clinical Notes

This is the most complex protocol in the library β€” it should not be initiated without full baseline laboratory work and ideally physician oversight. MOTS-c, a mitochondrial-derived peptide, activates AMPK to improve cellular energy metabolism and has shown remarkable longevity data in animal models. Epithalon (tetrapeptide Ala-Glu-Asp-Gly) activates telomerase and normalizes pineal melatonin production β€” given in pulsed courses, not continuous. The GH secretagogue combination ensures anabolic support while TA-1 maintains immune surveillance against accumulating cellular errors.

Case Study

Clinical Practice Example

Female, 61, post-menopausal, biological age tested at 68 years (GrimAge). Presenting with severe fatigue, cognitive decline, and VO2max of 22 mL/kg/min. Completed 16-week advanced protocol with full monitoring. At week 16: GrimAge re-test showed biological age 63 (5-year reduction). IGF-1 from 74 to 156 ng/mL. VO2max improved to 29 mL/kg/min. Patient described it as 'the most significant health transformation of my life'.

← Back to all protocols